Melanotan

Melanotan II 10 mg is offered by SARMs Revolution Lab strictly for laboratory research in Canada. This page explains the molecule’s research context, evidence limits and known safety concerns without presenting it as a tanning product, medication or treatment.

Melanotan II 10 mg Research Product Information

The 10 mg designation identifies the stated quantity in the vial. It is not a dosage or administration recommendation.

What Is Melanotan II?

Melanotan II is a synthetic cyclic analogue of alpha-melanocyte-stimulating hormone (α-MSH). It interacts with multiple melanocortin receptors, a receptor family studied in pigmentation, appetite, sexual signalling and other physiological processes. Its broad receptor activity is also one reason that effects observed in research should not be reduced to a simple cosmetic claim.

What Does the Published Literature Show?

Published work includes receptor and laboratory studies, observational reports and case reports involving people who obtained Melanotan II outside regulated clinical channels. This is not a mature evidence base establishing safe cosmetic use. A 2020 case report and literature review discussed renal infarction after Melanotan II exposure and noted earlier reports involving rhabdomyolysis and renal failure. A 2021 qualitative study examined user experiences reported in online forums; self-reported forum data can identify concerns, but it cannot establish safety or effectiveness.

These publications concern reported exposures and research preparations, not the identity or performance of an SRL vial. They should be used to understand uncertainty and risk, not as instructions for use.

Regulatory Context in Canada

Health Canada warns consumers about unauthorized injectable peptide drugs sold online and advises that a “For Research Use Only” label does not remove regulatory requirements. SRL does not present this product as an approved drug, tanning treatment or cosmetic.

How Should Melanotan II Research Be Interpreted?

• Receptor activity does not prove a safe or appropriate human application.
• Case reports can signal possible harms but cannot calculate the frequency of those harms.
• Online testimonials are not controlled clinical evidence.
• Product identity, purity, stability and regulatory authorization are separate questions.

Frequently Asked Questions About Melanotan II

Is Melanotan II the same as Melanotan I?

No. They are different synthetic melanocortin analogues with different molecular structures, receptor profiles and research histories.

Is this Melanotan II vial approved as a tanning product?

No. SRL offers it strictly as laboratory research material, not as a medication, cosmetic or tanning treatment.

What does 10 mg mean on the vial?

It is the stated total quantity of material in the vial. It does not describe a dose, protocol or frequency of use.

Does SRL provide dosing, reconstitution or injection instructions?

No. Those instructions are not provided because the product is not intended for human or veterinary administration.

How should a Melanotan II research vial be stored?

Researchers should rely on current lot-specific documentation and their institution’s laboratory protocol. Generic instructions copied from other peptides may not be appropriate for a particular formulation.

Where can researchers browse other peptide materials?

Browse the Canadian research peptide catalogue.

Scientific and Regulatory References

• Peters B et al. Melanotan II: a possible cause of renal infarction — case report and literature review. 2020.
• Gilhooley E et al. Melanotan II User Experience: a qualitative study of online discussion forums. 2021.
• Health Canada warning concerning unauthorized injectable peptide drugs.

Research-use notice: Melanotan II 10 mg is offered strictly for laboratory research and analytical work. It is not intended for human consumption, self-administration, diagnosis, treatment, cosmetic use or veterinary use.